Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageMerit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. We strive to be the most customer-focused company in healthcare. Each day we are determined to make a difference by understanding our customers’ needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Business segments
Jun 2026 · $394.9MThe company’s own SEC segment disclosure.
- Therapeutic$137.9M35%
- Foundational Original Equipment Manufacturer$48.3M12%
- Foundational Vascular Intervention$41.7M11%
- Therapeutic Vascular Intervention$34.4M9%
- Therapeutic Cardiac Therapies$28.5M7%
- Foundational Procedural Solutions$27.9M7%
- Other (5)$76.2M19%
Merit Medical Systems, Inc. (MMSI) reported revenue of $382M in Q1 2026 (quarter ended Mar 31, 2026), up 7.5% from the same quarter a year earlier. That came with a gross margin of 48% and net income of $41M (11% of revenue). For the full year FY2025, revenue was $1.52B (+12% year on year) and net income $128M. Its largest product in Jun 2026 was Therapeutic at $138M, 35% of the disclosed total, well ahead of Foundational Original Equipment Manufacturer at 12%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #14 of 19 by Smart Score